Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Sodium Thiosulfate (STS) for Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) Undergoing Concurrent Chemoradiation With Cisplatin

NCT04541355 is registered in ClinicalTrials.gov with Hyunseok Kang, MD as lead sponsor.

NCT NCT04541355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04541355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Sodium Thiosulfate (STS) for Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) Undergoing Concurrent Chemoradiation With Cisplatin
Lead sponsor
Hyunseok Kang, MD
Phase
Phase 2
Overall status
Completed
Start date
October 14, 2020
Completion date
May 31, 2023
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage iii human papillomavirus (hpv)-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, clinical stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, locally advanced head and neck squamous cell carcinoma, locally advanced hypopharyngeal squamous cell carcinoma, locally advanced laryngeal squamous cell carcinoma, locally advanced oral cavity squamous cell carcinoma, locally advanced oropharyngeal squamous cell carcinoma, pathologic stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, pathologic stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, stage iii hypopharyngeal carcinoma ajcc v8, stage iii laryngeal cancer ajcc v8, stage iii lip and oral cavity cancer ajcc v8, stage iii oropharyngeal (p16-negative) carcinoma ajcc v8, stage iv hypopharyngeal carcinoma ajcc v8, stage iv laryngeal cancer ajcc v8, stage iv lip and oral cavity cancer ajcc v8, stage iv oropharyngeal (p16-negative) carcinoma ajcc v8, stage iva hypopharyngeal carcinoma ajcc v8, stage iva laryngeal cancer ajcc v8, stage iva lip and oral cavity cancer ajcc v8, stage iva oropharyngeal (p16-negative) carcinoma ajcc v8, stage ivb hypopharyngeal carcinoma ajcc v8, stage ivb laryngeal cancer ajcc v8, stage ivb lip and oral cavity cancer ajcc v8, stage ivb oropharyngeal (p16-negative) carcinoma ajcc v8, stage ivc hypopharyngeal carcinoma ajcc v8, stage ivc laryngeal cancer ajcc v8, stage ivc lip and oral cavity cancer ajcc v8, stage ivc oropharyngeal (p16-negative) carcinoma ajcc v8